Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Cardiology/Vascular Diseases | Pulmonary/Respiratory Diseases | Family Medicine
Disease Category: Congestive Heart Failure
Location: United States, FL

Clinical Trial Details

Overview

Research Study Summary

Are you undergoing treatment for Congestive Heart Failure?

Purpose

Patients may be entered in the study who are>18 years of age with at least a 30-day history of NYHA Class II to IV HF and and any documented left ventricular ejection fraction within a year prior to screening and signs of volume overload.

Patient Inclusion Criteria:

  • History of chronic CHF requiring standard HF treatment including diuretics for a minimum of 30 days.

Patient Exclusion Criteria:

  • Heart attack or stroke within 30 days prior to screening.
  • Clinically significant valvular disease

To Learn more
Phase

2

Gender

Both Male and Female

Age

18 and up

Overall Status

Recruiting

Facility Type

N/A

Contact

Karen Renaud, Study Coordinator
Tampa Clinical Research
4290 W. Linebaugh Avenue
Tampa, FL 33624
Phone: 813-960-7070
Fax: 813-960-7979

View Map

Research Center Information: Tampa Clinical Research

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

CW ID: 164006

Date Last Changed: July 24, 2013


DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.